EFFECT OF 52 WEEKS OF MIRIKIZUMAB ON INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE SCORES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

Laurent Peyrin-Biroulet  1     Bruce E. Sands  2     William Sandborn  3     Peter D.R. Higgins  4     Fumihito Hirai  5     Vipul Jairath  6     Ruth Belin     Yan Dong     Elisa Gomez Valderas     Debra Miller     Vipin Arora     April Naegeli     Paul Pollack     Jay Tuttle     Toshifumi Hibi    
1 Nancy University Hospital Inserm U954,Vandoeuvre les Nancy,France
2 Icahn School of Medicine at Mount Sinai,New York,United States
3 University of California San Diego,La Jolla,United States
4 University of Michigan Health System School of Public Health,Ann Arbor,United States
5 Fukuoka University Chikushi Hospital,Chikushino,Japan
6 Unive

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing